Introduction {#section1-1559325819843375}
============

The effects of radiation depend on the dose and quality of the radiation as well as the sensitivity of the organism to radiation which can lead to a variety of different chromosome aberrations. Radiation exposure can affect cellular structural integrity, immune functions, cell cycle control, and apoptosis.^[@bibr1-1559325819843375],[@bibr2-1559325819843375]^ Radiation-induced alterations in the expression of genes responsible for the formation and maintenance of cellular structure and cell cycle control may lead to chromosome instability and carcinogenesis.^[@bibr2-1559325819843375][@bibr3-1559325819843375][@bibr4-1559325819843375]-[@bibr5-1559325819843375]^ In human cells, metabolic activities, environmental factors, or radiation can induce DNA damage, resulting in as many as 1 million individual molecular lesions per cell per day.^[@bibr6-1559325819843375]^ When the repair system fails or is not entirely successful, and cellular apoptosis does not occur, irreparable DNA damage may occur, including double-strand breaks and DNA cross linkages (interstrand crosslinks).^[@bibr7-1559325819843375],[@bibr8-1559325819843375]^ This damage may be stable, allowing the cells to pass through mitosis.

The dicentric chromosome assay (DCA) is a sensitive and specific method for assessing biodosimetry. At present, the DCA is the gold standard for radiation dose assessment according to ISO19238 and the International Atomic Energy Agency. It can be used to assess the effects of radiation doses from 0.2 to 5.0 Gy, independent of age and gender.^[@bibr9-1559325819843375]\ ,[@bibr10-1559325819843375]^ Fluorescence in situ hybridization is also used to measure the frequency of translocations and evaluate the effects of radiation dose.^[@bibr11-1559325819843375]^ Although the methods mentioned earlier identify the chromosomal rearrangements and translocation frequencies, they are not optimal for indicating the regions on chromosomes that are sensitive to aberrations. In this investigation, we observed the large-scale changes in chromosomes for obtaining the significant and obvious chromosome aberrance, especially in low-dose radiation. Furthermore, the adjustment for chromosome length was not performed in previous studies. More detailed observation and analysis will be used in the further study.

Radiation-induced DNA damage can be detected as large-scale rearrangements of the genome, and chromosomal aberrations induced by radiation appear to be approximately random across the whole genome.^[@bibr12-1559325819843375][@bibr13-1559325819843375][@bibr14-1559325819843375]-[@bibr15-1559325819843375]^ A previous study, however, has shown that chromosomes with high DNA content were less frequently involved in the formation of balanced translocations and dicentric chromosomes than would be expected, whereas smaller chromosomes were more frequently involved in the formation of these aberrations.^[@bibr11-1559325819843375]^

In this study, we attempted to identify chromosome regions that were susceptible to radiation exposure. We performed traditional Giemsa-trypsin-Wright (GTW)-banding staining to determine the specific translocation regions on the chromosomes and compared this with gene expression array data. We hypothesized that these translocation regions are linked to radiation sensitivity.

Materials and Methods {#section2-1559325819843375}
=====================

Sample Preparation {#section3-1559325819843375}
------------------

Whole blood samples (30 mL) from each of 3 apparently healthy participants were collected into vacutainer tubes containing sodium heparin. The groups enrolled in our study were having similar age (25∼30 years old), health status (no illness and no medicine), and 2 genders (included female and male). The samples were irradiated using ^60^Co at a dose rate of 0.546 Gy/min (0.0091 Gy/ sec) at the Institute of Nuclear Energy Research, in Taoyuan. The radiation doses used in these experiments were 0.5 (exposed to 55 seconds), 1 (exposed to 110 seconds), 2.5 (exposed to 275 seconds), and 5 Gy (exposed to 549 seconds). The control samples were not exposed to any radiation. Informed consent was obtained from all participants, and all procedures were approved by the Institutional Review Board at Tzu Chi General Hospital, Hualien.

Cytogenetic Analysis {#section4-1559325819843375}
--------------------

After irradiation, the samples were incubated at 37°C for 48 hours before being harvested.^[@bibr9-1559325819843375]^ Metaphase preparation was performed using a standard protocol for lymphocyte cultures based on the general guidance provided by the International Atomic Energy Agency and ISO 19238.^[@bibr9-1559325819843375],[@bibr10-1559325819843375]^ We used the [l]{.smallcaps}-form phytohemagglutinin (PHA), which is the mitogen that induces the T cell into cell division. We decided to analyze the T cells first. The GTW-banded chromosome was done using a standard protocol.^[@bibr16-1559325819843375]^ The breakpoints of chromosomal translocation were investigated on the metaphase chromosomes.

Scoring Chromosome Aberrations {#section5-1559325819843375}
------------------------------

The samples were scored for radiation-induced dicentrics and translocations according to previously published references.^[@bibr17-1559325819843375],[@bibr18-1559325819843375]^ For each dose, 50 metaphase cells were analyzed per sample as stipulated by the criteria for performing triage quality dose assessments.^[@bibr19-1559325819843375],[@bibr20-1559325819843375]^ The accuracy of dose assessments after scoring only 50 cells is considered sufficient in a preliminary triage during a mass-casualty event.^[@bibr17-1559325819843375][@bibr18-1559325819843375][@bibr19-1559325819843375]-[@bibr20-1559325819843375]^ The slides were scanned at low magnification (100×) to avoid personal bias and then analyzed at high magnification (1000×). Only spread metaphase cells with 46 centromeres were scored.

Chromosome Aberration Analysis {#section6-1559325819843375}
------------------------------

The identity and number of chromosome translocation sites were mapped on each chromosome. The chromosomal aberration sites were considered for aberrations that were detected at least twice or with more than 2 radiation doses. The hit frequencies of translocations in each chromosome at different radiation doses were estimated by using the translocation hit number adjusted according to the length (Mbp) of each chromosome arm. We used ISCN 2016 guideline to describe the chromosome aberration.

Microarray Data Acquisition and Analysis {#section7-1559325819843375}
----------------------------------------

Microarray data generated in our previous study^[@bibr21-1559325819843375]^ were reanalyzed in this study. The alterations in genes (including increased and decreased gene expression after different doses of radiation exposure) selected from microarray analysis according to a fold-change \>3 or \<−3 and a *P* value \<.0001 were mapped on each chromosome according to the location of the genes. The number of altered genes in each chromosome arm at various radiation doses was estimated by adjusting the number of altered genes according to the total number of genes in each arm of the chromosome.

### Chromosome aberrant regions annotation {#section8-1559325819843375}

We try to find radiation sensitive chromosome regions, and these aberrant regions should link to different dose of ionizing radiation. Furthermore, we investigate the aberrant chromosome regions may harbor some disease susceptibility genes. We search potential related genes involved in the break chromosome regions from these websites: the Atlas of Genetics and Cytogenetics in Oncology and Hematology website (<http://www.atlasgeneticsoncology.org/>), Cancer Genetics Web (<http://www.cancerindex.org/geneweb/>), and NCBI/OMIM (<https://www.ncbi.nlm.nih.gov/omim>).

Results {#section9-1559325819843375}
=======

Examples of chromosome aberrations induced by different doses of radiation exposure are shown in [Figure 1](#fig1-1559325819843375){ref-type="fig"}. The chromosome aberrations include different structural abnormalities such as ring chromosomes in [Figure 1](#fig1-1559325819843375){ref-type="fig"}, acentric chromosomes, deletions, and double minutes, translocation, and dicentric chromosome. [Figure 2](#fig2-1559325819843375){ref-type="fig"} shows 2 sample karyotypes for the cells all exposed to 5 Gy of radiation with more detail.

![Chromosomal variations induced by different radiation doses. The arrows indicate the translocation and chromosome aberrations, which were observed at various radiation dose as follows: (A and B): 0 Gy; (C and D): 0.5 Gy; (E and F): 1 Gy; (G and H): 2.5 Gy; (I and J): 5 Gy. The number (count) of chromosome aberrations was as follows: 0 for (A and B), 2 for (C and D), 3 for (E and F), 6 for (G and H), and 12 for (I and J).](10.1177_1559325819843375-fig1){#fig1-1559325819843375}

![Karyotypes demonstrated in cells exposed to 5 Gy of radiation. Arrows indicate deletions (del), translocations (t), chromosome breaks (chrb), ring chromosomes (r), and acentric fragments; t(3;4): breakage and reunion have occurred at chromosome 3q and 4q. The segments distal to these q arms have been exchanged; del (10) (with a star): interstitial deletion without reunion; chrb(14): chromosome 14 break which is synonymous with isochromatid break; r(X) and del(X): t derivative deleted chromosome X, one part reunion became a ring chromosome, another part remained as a chromosome X fragment, and other parts of this chromosome X was missing.](10.1177_1559325819843375-fig2){#fig2-1559325819843375}

[Figure 3](#fig3-1559325819843375){ref-type="fig"} shows the chromosome aberrations mapped by radiation exposure. This map indicates the chromosome aberrations that were induced by radiation exposure, which appeared in locations in a nonrandom manner, that is, more than once or induced by more than 1 dose of radiation. Some specific chromosome regions were highly radiosensitive, and the translocations occurred mainly in light G-bands (ie, the euchromatic region).

![Chromosome aberration map after different doses of ^60^Co radiation exposure. Karyotypes illustrate the positions of the translocations. Stars show the number of translocations from the 150 cells analyzed.](10.1177_1559325819843375-fig3){#fig3-1559325819843375}

[Figure 4](#fig4-1559325819843375){ref-type="fig"} shows the random count of translocation for each of the chromosome arms. The estimated frequency for chromosome translocations is adjusted according to the chromosome length (obtained from the NCBI). Chromosomes 18, 17, and 1 were the chromosomes with the highest frequencies of translocations per length of chromosome. However, chromosomes 3 and 9 showed the highest sensitivity to 0.5 Gy of radiation. The data revealed that chromosome 18 had the highest frequency of translocations with high doses of radiation. This chromosome was not sensitive to radiation of 0.5 Gy compared to other chromosomes. Supplementary Table S1 shows the all translocation positions in each chromosome.

![Hit frequencies of translocations in each chromosome at different radiation doses. The stars indicate the top 5 chromosomes. The frequencies were estimated for sensitive chromosomal regions using the translocation hit number adjusted according to the length of the chromosome arms (Mbp).](10.1177_1559325819843375-fig4){#fig4-1559325819843375}

[Table 1](#table1-1559325819843375){ref-type="table"} shows the translocations that occurred on chromosomes 9q, 15q, and 17q more than 5 times and for at least 3 doses. In these regions, most of the genes were related to leukemia, particularly in chromosomes 9q and 15q. Translocations that appeared more than 5 times at 2 different radiation doses were associated with multiple types of cancer-related and tumorigenesis-related genes, such as *NFkB2* ([Table 2](#table2-1559325819843375){ref-type="table"}). [Table 3](#table3-1559325819843375){ref-type="table"} shows the translocations that appeared more than 4 times in the same chromosomal region after exposure to 5 Gy of radiation. *XRCC4* gene locates to chromosome 5q and acts in DNA double-strand break repair. The *TCRD* gene is involved in Ataxia telangiectasia mutated (ATM)-deficient thymic lymphoma. Translocations that appeared more than 4 times in the same chromosomal region following exposure to 1 or 2.5 Gy of radiation are shown in [Table 4](#table4-1559325819843375){ref-type="table"}. Two examples, *BCL6* and *PTPRC* genes, are associated with B-cell lymphoma and acute myeloid leukemia, respectively. The results showed in [Tables 1](#table1-1559325819843375){ref-type="table"} and [2](#table2-1559325819843375){ref-type="table"} were searched from the Atlas of Genetics and Cytogenetics in Oncology and Hematology website, Cancer Genetics Web, and NCBI/OMIM.

###### 

Chromosome Regions With More Than 5 Translocations Following Radiation Exposure at Doses of 0.5, 1, 2.5, and 5 Gy (the Number of Translocations Appeared With at least 3 Different Radiation Doses).

![](10.1177_1559325819843375-table1)

  -----------------------------------------------------------------------------------------------------------------
  Location    Gene^a^                  Disease^b^                               Common Cytogenetic Aberrations^b^
  ----------- ------------------------ ---------------------------------------- -----------------------------------
  9q34        *SET*                    Myeloid leukemia-associated\             t(6;9)(p23;q34)\
                                       Wilms' tumor                             t(7;9)(q34;q34.3)\
                                                                                t(9;22)

  9q34.1      *ABL1*                   Chronic myelogenous leukemia             

  *NUP214*    Acute myeloid leukemia                                            

  9q34.3      *NOTCH1*                 Neoplastic transformation                

  15q21-q22   *B2M*                    Multiple myeloma                         t(15;17)

  15q22       *PML*                    Promyelocytic leukemia                   

  15q22-q24   *CYP1A1*                 Childhood acute lymphoblastic leukemia   

  17p13.1     *TP53 (P53)*             Li-Fraumeni syndrome\                    Loss of 17p
                                       Neuroectodermal tumors\                  
                                       Medulloblastoma\                         
                                       JPAs in children                         
  -----------------------------------------------------------------------------------------------------------------

^a^Cancer-related genes within the chromosome translocation sites.

^b^Data obtained from the Atlas of Genetics and Cytogenetics in Oncology and Hematology website, Cancer Genetics Web, and NCBI/OMIM.

###### 

Chromosome Regions With More Than 5 Translocations Following Radiation Exposure at 0.5, 1, 2.5, or 5 Gy (the Number of Translocations Appeared With at least 2 Different Radiation Doses).

![](10.1177_1559325819843375-table2)

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Location                 Gene                                                                           Diseases                                                              Common Cytogenetic Aberrations
  ------------------------ ------------------------------------------------------------------------------ --------------------------------------------------------------------- --------------------------------
  1p13.3                   *RAP1A*                                                                        Human tumors                                                          

  1p32                     *TAL1 (SCL, TCL5)*                                                             T-cell acute lymphocytic leukemia                                     

  *EPS15 (MLLT5, AF-1P)*                                                                                                                                                        

  *CDKN2C (p18)*           Inhibits CDK4                                                                                                                                        

  1p32-p31                 *JUN*                                                                          V-jun avian sarcoma virus 17 oncogene homolog                         

  3p26-p25                 *VHL*                                                                          Von Hippel-Lindau syndrome                                            

  4p11-q22                 *KIT*                                                                          Gastrointestinal stromal tumors                                       

  7q32-q36                 *EPHA1*                                                                        Hepatoma                                                              

  9q22                     *NR4A3 (CHN, CSMF)*                                                            Extra-skeletal myxoid chondrosarcoma                                  t(9;22)(q22-31;q11-12)

  *SYK*                    Breast cancer\                                                                                                                                       
                           B-cell lymphomas\                                                                                                                                    
                           Colorectal cancer                                                                                                                                    

  9q22.3                   *PTCH*                                                                         Nevoid basal cell carcinoma syndrome\                                 
                                                                                                          Gorlin syndrome                                                       

  *FANCC*                  Fanconi anemia                                                                                                                                       

  10q24                    *NFKB2 (p49/p100)*                                                             Abnormal cell proliferation\                                          t(10;14)(q24;q11)\
                                                                                                          Tumorigenesis\                                                        t(1;10)
                                                                                                          Hepatocarcinogenesis                                                  

  *HOX11 (TCL3)*           T-cell lymphoma                                                                                                                                      

  *PLAU*                   Multiple types of cancer                                                                                                                             

  10q24.1                  *TNFRSF6*                                                                      Tumor formation and defense\                                          
                                                                                                          Leukemia                                                              

  10q24.1-q24.3            *MGEA5*                                                                        Hyaluronidase in meningioma\                                          
                                                                                                          Bladder cancer                                                        

  11p15                    *NUP98*                                                                        Myelodysplastic syndromes\                                            t(7;11)(p15;p15)\
                                                                                                          Adult acute myeloid leukemia                                          t7;11)\
                                                                                                                                                                                t(11;14)(p15;q11)

  *LMO1*                   T-cell acute lymphoblastic leukemia cell line activates multiple transcripts                                                                         

  11p15.2-p15.1            *TSG101*                                                                       Breast cancer\                                                        
                                                                                                          Neoplasm                                                              

  11p15.5                  *WT2 (MTACR1)*                                                                 Second Wilms' tumor\                                                  
                                                                                                          Familial Wiedemann-Beckwith syndrome                                  

  11pter-p13               *CD44*                                                                         Malignancies lymphomas\                                               
                                                                                                          Neuroblastoma                                                         

  11p15.5                  *IGF2*                                                                         Wide range of cancers\                                                
                                                                                                          Wilms' tumor                                                          

  *IGF2AS*                 Wilms' tumor                                                                                                                                         

  12q24.13                 *BCL7A*                                                                        Directly involved with Myc and IgH                                    t(8;14;12)(q24.1;q32.3;q24.1)

  13q14.1-q14.3            *LCP1 (PLS2)*                                                                  B-cell non-Hodgkin lymphoma\                                          t(3;13)(q27;q14)\
                                                                                                          Retinoblastoma                                                        13q deletion

  14q24.3                  *FOS*                                                                          Ovarian cancer\                                                       
                                                                                                          Bladder cancer\                                                       
                                                                                                          Inflammation-mediated skin tumorigenesis                              

  14q24.3-q31              *CHES1*                                                                        Areca nut extract-induced oral cancer                                 

  16p13.13-p13.12          *MYH11*                                                                        Acute myelomonocytic leukemia\                                        
                                                                                                          Acute myelomonoblastic leukemia\                                      
                                                                                                          Acute myeloid leukemia                                                

  20q13.3                  *GNAS*                                                                         Pseudohypoparathyroidism type 1a\                                     
                                                                                                          Pseudohypoparathyroidism type 1b\                                     
                                                                                                          Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism\   
                                                                                                          McCune-Albright syndrome\                                             
                                                                                                          Progressive osseous heteroplasia\                                     
                                                                                                          Polyostotic fibrous dysplasia of bone\                                
                                                                                                          Pituitary tumors                                                      
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Number of Translocations That Appeared More Than 4 Times in the Same Chromosomal Region After Exposure to 5-Gy Radiation, Along With the Related Genes and Their Functions.

![](10.1177_1559325819843375-table3)

  -----------------------------------------------------------------------------------------------------------------------------------------
  Location                         Gene                            Diseases                                Common Cytogenetic Aberrations
  -------------------------------- ------------------------------- --------------------------------------- --------------------------------
  1q21                             *MCL1*                          Preneoplastic and neoplastic disease\   t(1;14)(q21;q32)\
                                                                   Pancreatic cancers                      t(X;1)(p11;q21)\
                                                                                                           t(1;12)(q25;p13)\
                                                                                                           t(1;11)(q21;q23)

  *AF1Q (MLLT11, RP11-316M1.10)*   Leukemia\                                                               
                                   Acute myelomonocytic leukemia                                           

  1q21-q22                         *NTRK1*                                                                 

  1q21.3-q22                       *CD48*                          Lymphoid leukemia\                      
                                                                   Arthritis                               

  1q24-q25                         *HPC1*                          Hereditary prostate cancer              

  *ABL2*                           Leukemia                                                                

  3q21-q27                         *MME*                           Acute lymphoblastic leukemia            

  3q21-q28                         *TERC*                          Leukemia                                

  5q13-q14                         *XRCC4*                                                                 

  10p11.2                          *COT*                           Human cancer                            t(10;11)

  14q11.2                          *TCRD*                          ATM-deficient thymic lymphoma\          t(11;14)(p15;q11)
                                                                   Acute lymphoblastic leukemia            

  18p11.2                          *MC2R*                          Adrenocortical neoplasms                t(X;18)(p11.2;q11.2)
  -----------------------------------------------------------------------------------------------------------------------------------------

###### 

Translocations That Appeared More Than 4 Times in Chromosomal Regions After Exposure to Radiation at 1 and 2.5 Gy, Along With Related Genes and Their Functions.

![](10.1177_1559325819843375-table4)

  ---------------------------------------------------------------------------------------------------
  Location    Gene                  Diseases                         Common Cytogenetic Aberrations
  ----------- --------------------- -------------------------------- --------------------------------
  1 Gy                                                               

   1q31-q32   *PTPRC (CD45, LCA)*   Acute myeloid leukemia           

  2.5 Gy                                                             

   3q27       *BCL6*                B-cell lymphoid neoplasms\       t(3;11)(q27;q23.1)\
                                    B-cell non-Hodgkin's lymphoma\   t(3;14)(q27;q32)
                                    Diffuse large B-cell lymphomas   
  ---------------------------------------------------------------------------------------------------

The microarray analysis demonstrated that chromosomes 1, 5, 9, 11, 13, 14, 17, 19, and 22 exhibited suppression and enhancement of gene expression induced by radiation exposure, and the incidences of change were higher than that of other chromosomes ([Figure 5](#fig5-1559325819843375){ref-type="fig"}). We analyzed the percentage of altered genes among all genes in each chromosome arm and found that chromosomes 5, 9, 13, 16, 17, 19, and 22 had the highest percentages. In particular, the maximum percentage of upregulated genes was observed in chromosomes 17p/q, 19q, and 22q, whereas the majority of suppressed genes were observed in chromosomes 5p, 9q, 13q, and 16q ([Figure 6A and B](#fig6-1559325819843375){ref-type="fig"}).

![Gene expression map after different doses of ^60^Co radiation exposure. Karyotypes illustrate the position of up- or downregulated genes. Stars show the number of genes expressed (fold-change \>3 or \<−3; *P* \< .0001).](10.1177_1559325819843375-fig5){#fig5-1559325819843375}

![Number of up- and downregulated genes. (A) A high percentage of upregulated genes was found in chromosomes 17p/q, 19q, and 22q. Upregulated genes did not appear with low-radiation doses of 0.5 Gy, and 5-Gy doses also appeared to have fewer effects on genes. (B) A high percentage of downregulated genes was found in chromosomes 5p, 9q, 13q, and 16q (fold-change \>3 or \<−3; *P* \< .0001).](10.1177_1559325819843375-fig6){#fig6-1559325819843375}

Discussion {#section10-1559325819843375}
==========

In this study, we used G-banding to investigate the location of chromosome aberrations induced by various radiation doses and at the banding level of at least 400 bands. We found that some chromosome regions were more sensitive to radiation-induced, large-scale genomic rearrangement. Moreover, the greatest numbers of translocation occurred in the euchromatic regions. In addition, we compared our results to microarray data and found that chromosomes such as 9 and 17 were more sensitive to radiation.

The GC-rich regions are more frequently involved in transcription. Dark G-Bands are heterochromatic, AT-rich regions are less frequently involved with transcription. In heterochromatic regions, most genes are inactivated tissue-specific genes,^[@bibr22-1559325819843375]^ which are rarely involved in transcription. Heterochromatin protects the genes while they are not in use. Euchromatin participates in the active transcription of regulatory proteins and the binding of RNA polymerase complexes to DNA sequences for the initiation of the transcription process.^[@bibr23-1559325819843375]^ The results of the present study suggest the interaction of irradiation with more sensitive regions of the chromosome can induced more damage than when interacts with other regions of the chromosome as previously supposed. Indeed, our data indicate that the euchromatic region is more sensitive to radiation exposure. These results are similar to those of previous studies.^[@bibr24-1559325819843375]^

In chromosomes 1q, 9q, 15q, and 17, translocations appeared more than 5 times with different radiation doses; in 15q22 and 17p13, translocations appeared with 4 different doses. A comparison to the previous study showed that the aberration in chromosome 17p13 was found only in the bone marrow sample.^[@bibr25-1559325819843375]^ The *TP53* and *HIC1* genes were involved in the 17p13 region, whereas *B2M*, *PML*, and *CYP1A1* genes were involved in the 15q22 region. *PML* is a tumor suppressor protein from the dynamic macromolecular nuclear structure, the PML-nuclear body (PML-NB). The *PML* gene generates the oncogenic fusion protein PML-retinoic acid receptor-alpha. Disruption of PML-NBs is implicated in the pathogenesis of acute promyelocytic leukemia.^[@bibr25-1559325819843375],[@bibr26-1559325819843375]^

We found that 1p13 and 1q25, 3q21, 5q13, 10p11.2, and 14q11.2/q24 were more sensitive to high radiation dose after 5-Gy ^60^Co exposure. These results were inconsistent with a previous study,^[@bibr24-1559325819843375]^ which showed that chromosome regions 1p36, 2q33, 3p21, 4q31.1, 7q22, 8q22, and 12q24.1 of the lymphocyte sample were sensitive to 4-Gy ^60^Co exposure. Chromosome regions 3p21, 1q42, 7q32, 9p11/q11, 10q24, 14q24, and 17p13 of bone marrow samples were also sensitive to 4-Gy ^60^Co exposure.^[@bibr24-1559325819843375]^ This inconsistency between the 2 studies could be due to counting the regions with translocations and not counting the breakpoint distribution in the chromosomes in our investigation. The previous study also showed the breakpoint distribution within relatively fragile sites, either in the bone marrow sample or the lymphocyte sample. The breakpoints observed at 14q24 and 17p13 within these sites were only significantly found in bone marrow, and another breakpoint was observed at 2q25 in lymphocytes only.

However, we found that the chromosome 18p region had a high frequency of translocations when subjected to a high dose (2.5 Gy and 5 Gy) of radiation after adjusting for the length of the chromosome arms. This region reportedly possesses a significant loss of heterozygosity (LOH; 63%), with 56% occurring early in ductal carcinoma in situ in 96 microdissected breast cancer samples. Compared to LOH data, 18p LOH was found in conjunction with allelic deletions on 3p, 9p, 17p, and 17q.^[@bibr27-1559325819843375]^ The putative tumor suppressor gene *DAL-1* has recently been mapped to chromosome band 18p11.3.^[@bibr28-1559325819843375]^ High doses of radiation may influence these regional events, which are likely to be more varied depending on the stage and/or type of tumor foci analyzed. After adjusting for the length of the chromosome arms (Mbp), we found that 1p and 10p, 14q, 17p, and 18p had high frequencies of translocations, especially in 17p, where translocations were observed at all radiation doses (0.5 Gy, 1 Gy, 2.5 Gy, and 5 Gy).

In our previous study, we showed that gene expression was altered in some genes following exposure to 1 Gy of radiation. With 0.5 Gy of radiation dose, gene regulation remained unchanged; similarly, 5 Gy of radiation appeared not to affect some genes.^[@bibr21-1559325819843375]^ We analyzed the gene expression array data with the criteria of *P* \< .0001 and change \>3 or \<−3. We found that the number of downregulated genes increased in chromosomes 5p, 9q, 13q, and 16q, whereas the number of upregulated genes increased in chromosomes 17p/q, 19q, and 22q. By comparison with our chromosome data, it appears that chromosomes 9q and 17q are those most sensitive to radiation. In contrast to a previous study,^[@bibr24-1559325819843375]^ our findings demonstrated that some chromosome regions were more susceptible to radiation than others and that chromosome alteration occurred mainly in the light G-bands of the euchromatic region. In the previous review discussing the intrachromosomal and interarm distribution of radiation-induced breakpoints in the human genome, the data demonstrated that chromosomes 1, 9, 13, 14, 15, 21, and 22 had a significant probability of radiation-induced breakpoints per Mbp of DNA.^[@bibr29-1559325819843375]^ In comparison to our data, we used the expression array and adjusted it by the total number of genes in the chromosomes and arms. Chromosomes 1, 9, 15, and 17 were found to be more sensitive to radiation at 0.5 Gy.

Radiation exposure can cause the alteration in messenger RNA expression through direct or indirect effects. The direct effects may have been induced by nonobserved mutations caused by radiation, such as microdeletions/insertions and point mutations. The indirect effects are caused by their regulatory gene(s) being affected by radiation. The limitation of our comparison of chromosome aberrations and expression profiling is that the direct effects are not confirmed, and further investigation is needed. However, we still found some distinguished patterns from our preliminary data. Next-generation sequencing should be performed to investigate nonobserved chromosome/genomic aberrations.

In summary, our data, along with that of previous studies, showed that chromosomes 1, 3, 7, 10, 14, and 17 had aberration distributions similar to lymphocyte samples in previous studies. Chromosomes 5, 14, and 17 showed results similar to a bone marrow sample from a previous study.^[@bibr24-1559325819843375],[@bibr29-1559325819843375]^ This finding provided information for the selection of sensitive reference chromosomes in relationship with low-radiation doses (under 0.5 Gy). In particular, focusing on these 4 chromosomes should be helpful in the determination of chromosome variation of dose less than 1 Gy.

Supplemental Material {#section11-1559325819843375}
=====================

###### Supplementary_Table - The Potential Effect of Different Doses of Ionizing Radiation on Genes and Disease

###### 

Click here for additional data file.
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